Co- CEO

Anthony G. Viscogliosi is a visionary entrepreneur, investor, and strategist with an extensive track record in the neuro-musculoskeletal and orthopedic industries. As the co-founder of Viscogliosi Brothers, LLC, he has played a pivotal role in launching and managing over 43 companies and 28 investment funds, raising more than $2 billion in capital. His leadership has driven multiple successful exits, with companies under his guidance generating over $2.9 billion in proceeds. A recognized innovator, Anthony has co-founded and led numerous groundbreaking companies, including Small Bone Innovations, Inc., which achieved record-breaking venture financing and was later acquired by Stryker Corporation for $375 million.

Beyond his business achievements, he has had an influential career on Wall Street, serving as one of the first orthopedic industry analysts and investment bankers. He is also a U.S. Navy veteran, philanthropist, and advocate for entrepreneurship, education, healthcare, and veterans' affairs. His dedication to community development, historical preservation, and national security further underscores his commitment to making a lasting impact.

Co-CEO

John J. Viscogliosi is a seasoned executive, investor, and entrepreneur with over 20 years of experience in the neuro-musculoskeletal industry. As President, CEO, and Chairman of Viscogliosi Brothers Acquisition Corporation, he leads an $86 million Special Purpose Acquisition Company focused on healthcare and medical technology. Previously, he was Chairman and CEO of Centinel Spine, where he transformed the company into the largest privately held spinal health business specializing in anterior column reconstruction. Under his leadership, Centinel Spine acquired Prodisc from Johnson & Johnson, expanded its global presence, and significantly improved patient access to lumbar total disc replacements.

A founding member of Viscogliosi Brothers, LLC, John has played a pivotal role in launching and scaling numerous musculoskeletal companies, including Paradigm Spine, Small Bone Innovations, and Spine Solutions. He has served on multiple boards and contributed to high-profile acquisitions by major medical companies like Johnson & Johnson and Zimmer Holdings. Before his entrepreneurial success, he built a strong financial background as a Vice President of Investments at Stifel, Nicolaus & Co. and held key roles at Rodman & Renshaw and First of Michigan Corp. He holds a B.S. in Criminal Justice from Wayne State University.

Co-CEO

Marc R. Viscogliosi is a seasoned CEO, investor, and industry innovator with over 25 years of success in the medical technology field. As a co-founder of Viscogliosi Brothers, LLC, he has played a key role in raising over $1 billion in capital and generating $2.7 billion in exit proceeds. With more than two dozen issued medical device patents, multiple FDA PMA approvals, and expertise in payer coverage policy development, he has led numerous startups to become high-growth, high-performance organizations.

Marc has founded and led several musculoskeletal companies, including Spine BioPharma, Paradigm Spine, Knee Creations, and MCRA. Before his entrepreneurial ventures, he worked as a Wall Street institutional equity research analyst, covering the neuro-musculoskeletal industry. He holds a B.A. in Economics and Political Science from New York University and continues to drive innovation and investment in the musculoskeletal sector.